tirzepatide news october 2025 Medscape | The FDA approved Zepbound in December 2024 for the treatment of moderate-to-severe obstructive sleep apnea in patients with obesity after Weight-loss jab Mounjaro trial begins

Conversely, estrogen therapy can affect glucose metabolism and insulin sensitivity, though effects vary based on formulation, dose, and route of administration

Branded medications are usually filled at a local retail pharmacy

Despite the strong influx of generics, innovator semaglutide brands continued to maintain healthy momentum, highlighting sustained physician and patient confidence in established brands

The average time from transplantation to diagnosis is three to eight years, and more than 90% of tumors are BCC or SCC

[2] Some patients discover too late that slowed digestion from GLP-1s can make oral birth control less effective, while others may be prescribed GLP-1 medications by their fertility doctors

A drug can move a fluid biomarker in the apparently favourable direction and still fail the patient